CUSIP NO. 584949 10 1 Page 1 of 5 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2)FN1
MEDQUIST INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, NO PAR VALUE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
584949 10 1
- --------------------------------------------------------------------------------
(CUSIP Number)
Welsh, Carson, Anderson William J. Hewitt, Esq.
& Stowe VI, L.P. Reboul, MacMurray, Hewitt,
320 Park Avenue, Suite 2500 Maynard & Kristol
New York, New York 10022 45 Rockefeller Plaza
Attention: Jonathan Rather New York, New York 10111
TEL. (212) 893-9500 TEL. (212) 841-5700
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
DECEMBER 13, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box [ ].
- --------
1 The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page. The information required
on the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
<PAGE>
CUSIP NO. 584949 10 1 Page 2 of 5 Pages
1) Name of Reporting Person Welsh, Carson, Ander-
I.R.S. Identification son & Stowe VI, L.P.
No. of Above Person
(Entities Only)
- --------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [X]
if a Member of a Group (b) [ ]
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Source of Funds Not Applicable
- --------------------------------------------------------------------------------
5) Check if Disclosure of
Legal Proceedings Is Not Applicable
Required Pursuant to
Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6) Citizenship or Place
of Organization Delaware
- --------------------------------------------------------------------------------
Number of 7) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Person With --------------------------------------------------------
8) Shared Voting
Power -0-
--------------------------------------------------------
9) Sole Disposi- -0-
tive Power
--------------------------------------------------------
10) Shared Dis-
positive Power -0-
--------------------------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- --------------------------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11)
Excludes Certain Shares
- --------------------------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- --------------------------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP NO. 584949 10 1 Page 3 of 5 Pages
1) Name of Reporting Person WCAS Healthcare
I.R.S. Identification Partners, L.P.
No. of Above Person
(Entities Only)
- --------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [X]
if a Member of a Group (b) [ ]
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Source of Funds Not Applicable
- --------------------------------------------------------------------------------
5) Check if Disclosure of
Legal Proceedings Is Not Applicable
Required Pursuant to
Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6) Citizenship or Place
of Organization Delaware
- --------------------------------------------------------------------------------
Number of 7) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Reporting Person --------------------------------------------------------
With 8) Shared Voting
Power -0-
--------------------------------------------------------
9) Sole Disposi- -0-
tive P
--------------------------------------------------------
10) Shared Dis-
positive Power -0-
--------------------------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- --------------------------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11)
Excludes Certain Shares
- --------------------------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- --------------------------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP NO. 584949 10 1 Page 4 of 5 Pages
AMENDMENT NO. 2 (FINAL AMENDMENT) TO SCHEDULE 13D
Reference is hereby made to the statement on Schedule 13D originally
filed with the Securities and Exchange Commission (the "SEC") on December 11,
1998 and Amendment No. 1 thereto filed on May 3, 1999 (as so amended, the
"Schedule 13D"). Terms defined in the Schedule 13D are used herein as so
defined.
The Schedule 13D is hereby amended as follows:
Item 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is hereby amended and restated to read in its entirety as
follows:
(a)
WCAS VI AND VI PARTNERS
WCAS VI and VI Partners own no shares of Common Stock.
WCAS HP AND HP PARTNERS
WCAS HP and HP Partners own no shares of Common Stock.
(b) Not Applicable
(c) On December 13, 1999 WCAS VI and WCAS HP distributed 1,775,884
and 38,879 shares, respectively, of Common Stock to their respective partners.
Such distributions represented the disposition of all of the Common Stock held
by WCAS VI and WCAS HP.
(d) Not Applicable
(e) The Reporting Persons ceased to be the beneficial owners of more
than five percent of the Common Stock on December 13, 1999.
<PAGE>
CUSIP NO. 584949 10 1 Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WELSH, CARSON, ANDERSON & STOWE VI, L.P.
By: WCAS VI Partners, L.P., General
Partner
By: /S/ JONATHAN RATHER
-----------------------------
Attorney-in-Fact
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By: /S/ JONATHAN RATHER
-----------------------------
Attorney-in-Fact
Dated: January 7, 2000
